Lack of cross neutralization by SARS patient sera towards SARS-CoV-2

Lack of cross neutralization by SARS patient sera towards SARS-CoV-2

10.1080/22221751.2020.1761267

Saved in:

Bibliographic Details
Main Authors:	Danielle Anderson, Chee Wah Tan, WanNi Chia, Barnaby Young, Martin Linster, Jenny Low, Yee Joo Tan, Mark I-Cheng Chen, Gavin Smith, Lin-Fa Wang, David Lye, Yee Sin Leo
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Letter
Published:	Taylor & Francis 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/191297
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
by: Piyada Supasa, et al.
Published: (2022)

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
by: Jiandong Huo, et al.
Published: (2020)

Acute onset of bilateral follicular conjunctivitis in 2 patients with confirmed SARS-CoV-2 infections
by: Louis Lim, et al.
Published: (2020)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
by: Wang, Bei, et al.
Published: (2022)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
by: Wang, Bei, et al.
Published: (2021)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
by: Rujas, Edurne, et al.
Published: (2022)

Serological differentiation between COVID-19 and SARS infections
by: WanNi Chia, et al.
Published: (2021)

Glycan engineering of the sars-cov-2 receptor-binding domain elicits cross-neutralizing antibodies for sars-related viruses
by: Ryo Shinnakasu, et al.
Published: (2022)

A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
by: Chotiwat Seephetdee, et al.
Published: (2022)

A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
by: Seephetdee C.
Published: (2023)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
by: Wang, Bei, et al.
Published: (2022)

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
by: Daming Zhou, et al.
Published: (2022)

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
by: Zheng Z, et al.
Published: (2021)

PESI: paratope-epitope set interaction for SARS-CoV-2 neutralization prediction
by: Wan, Zhang, et al.
Published: (2024)

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
by: Daming Zhou, et al.
Published: (2020)

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
by: Tan, Anthony T., et al.
Published: (2022)

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: an observational study
by: Young, Barnaby Edward, et al.
Published: (2022)

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
by: Young, Barnaby E, et al.
Published: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
by: Chang Liu, et al.
Published: (2022)

A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
by: Gan, Esther S., et al.
Published: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
by: Shan, Sisi, et al.
Published: (2022)

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
by: Zakir, Tasnim Saifudin, et al.
Published: (2022)

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.
by: Wan Ni Chia, et al.
Published: (2021)

Spike s2 subunit: The dark horse in the race for prophylactic and therapeutic interventions against sars-cov-2
by: Ng, Kim Tien, et al.
Published: (2022)

Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays
by: Tham, JWM, et al.
Published: (2021)

Mice immunized with the vaccine candidate hexapro spike produce neutralizing antibodies against sars-cov-2
by: Chotiwat Seephetdee, et al.
Published: (2022)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
by: Kaewchim K.
Published: (2023)

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
by: Kongsuphol, Patthara, et al.
Published: (2023)

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
by: Ferreira, Isabella ATM, et al.
Published: (2024)

Serological differentiation between COVID-19 and SARS infections
by: Chia, Wan Ni, et al.
Published: (2021)

Finger stick blood test to assess postvaccination SARS-CoV-2 neutralizing antibody response against variants
by: Lim, Sing Mei, et al.
Published: (2022)

Finger stick blood test to assess postvaccination SARS-CoV-2 neutralizing antibody response against variants
by: Lim, Sing Mei, et al.
Published: (2023)

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
by: NG KIM TIEN, et al.
Published: (2021)

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
by: Goh, Yun Shan, et al.
Published: (2024)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
by: Wang, R, et al.
Published: (2022)

Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions
by: Yang, Siwy Ling, et al.
Published: (2022)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
by: Ku, Zhiqiang, et al.
Published: (2023)

Rapid production of clinical-grade SARS-CoV-2 specific T cells.
by: Leung, Wing, et al.
Published: (2022)

Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors
by: Phakaratsakul S.
Published: (2023)

Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
by: Ju, Bin, et al.
Published: (2023)